Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
Status:
Not yet recruiting
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess whether there are differences in PERITONEAL RECURRENCE in
patients with Colon Cancer Peritoneal Metastases treated with complete surgical resection and
systemic chemotherapy, with (Group 1) or without (Group 2) HIPEC with Mitomycin-C.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Universitario de Fuenlabrada
Collaborator:
Instituto de Investigación Hospital Universitario La Paz